IL10 and COVID-19: This evidence further supports an involvement of inflammatory process in COVID-19-associated chemosensory dysfunction and suggests a role for IL-10 as reliable predictor of OD/GD course as well as potential pharmacological strategy to reach a successful recovery in post-COVID-19 patients.